Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.64
-0.36 (-4.00%)
At close: Jul 19, 2024, 4:00 PM
8.53
-0.11 (-1.27%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
MRVI Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MRVI stock have an average target of 11.44, with a low estimate of 7.00 and a high estimate of 17. The average target predicts an increase of 32.41% from the current stock price of 8.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MRVI stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -18.98% | Jul 9, 2024 |
Baird | Baird | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +15.74% | May 9, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +73.61% | Apr 10, 2024 |
RBC Capital | RBC Capital | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +62.04% | Feb 23, 2024 |
Stifel | Stifel | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +15.74% | Feb 23, 2024 |
Financial Forecast
Revenue This Year
280.72M
from 288.95M
Decreased by -2.85%
Revenue Next Year
307.62M
from 280.72M
Increased by 9.58%
EPS This Year
-0.02
from -0.90
EPS Next Year
0.04
from -0.02
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 295.0M | 346.2M | 416.6M | 453.3M | 566.6M |
Avg | 280.7M | 307.6M | 357.0M | 440.3M | 550.4M |
Low | 264.6M | 282.9M | 323.4M | 423.0M | 528.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.1% | 23.3% | 35.4% | 26.9% | 28.7% |
Avg | -2.8% | 9.6% | 16.1% | 23.3% | 25.0% |
Low | -8.4% | 0.8% | 5.1% | 18.5% | 20.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.04 | 0.12 | 0.14 | 0.23 | 0.40 |
Avg | -0.02 | 0.04 | 0.11 | 0.22 | 0.39 |
Low | -0.03 | -0.01 | 0.06 | 0.22 | 0.37 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 214.9% | 118.1% | 77.8% |
Avg | - | - | 144.4% | 111.8% | 72.7% |
Low | - | - | 35.6% | 103.5% | 66.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.